Blueshift Asset Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,067	Closed	-$239K	–	621
2025 Q1	$239K	Buy	+1,067	New	+$294K	0.09%	316
2024 Q3	–	Sell	-1,001	Closed	-$330K	–	487
2024 Q2	$330K	Buy	1,001 +467	+87%	+$165K	0.11%	228
2024 Q1	$211K	Sell	534 -1,265	-70%	-$468K	0.11%	251
2023 Q4	$633K	Buy	1,799 +1,178	+190%	+$417K	0.34%	81
2023 Q3	$233K	Buy	+621	New	+$240K	0.14%	228
2023 Q1	–	Sell	-2,277	Closed	-$536K	–	475
2022 Q4	$536K	Sell	2,277 -916	-29%	-$217K	0.25%	111
2022 Q3	$786K	Sell	3,193 -2,908	-48%	-$886K	0.17%	176
2022 Q2	$1.84M	Buy	+6,101	New	+$1.99M	0.3%	82
2021 Q4	–	Sell	-15,314	Closed	-$6.5M	–	1265
2021 Q3	$6.5M	Buy	15,314 +7,412	+94%	+$3.12M	0.36%	55
2021 Q2	$2.84M	Buy	+7,902	New	+$2.61M	0.16%	164
2021 Q1	–	Sell	-2,685	Closed	-$761K	–	1103
2020 Q4	$761K	Buy	+2,685	New	+$753K	0.09%	319
2020 Q3	–	Sell	-8,783	Closed	-$2M	–	795
2020 Q2	$2M	Buy	+8,783	New	+$1.73M	0.32%	93
2019 Q2	–	Sell	-9,282	Closed	-$1.02M	–	992
2019 Q1	$1.02M	Buy	+9,282	New	+$965K	0.14%	236